Suppression of Matrix Metalloproteinases -2 and -9 in Various Human Cancer Cell Lines by a Nutrient Mixture
Journal Title: Journal of Oncobiomarkers - Year 2015, Vol 2, Issue 1
Abstract
The matrix metalloproteinases (MMPs) are a family of zinc containing endopeptidases that degrade various components of the extra cellular matrix. Among the many types of MMPs that have been identified, MMP-2 (gelatinase A) and MMP-9 (gelatinase B) are thought to play a key role in cancer metastasis. These MMPs are able to modify tumor microenvironment by degrading type IV collagen found in the cellular basement membrane. MMP-2 and -9 are essential in facilitating cancer cell invasion, tumor progression, and metastasis, thereby shortening patient survival in all cancer types. A significant association has been reported between tumor aggression and increased levels of MMP-2 and MMP-9. Therefore, MMPs are used as diagnostic and prognostic biomarkers in many clinical trials and experimental studies. MMP inhibitors (MMPIs) seem to be the logical targets for the therapeutic intervention in cancer. The rationale for developing MMPIs for halting cancer has been around for more than three decades. However, the clinical trials of synthetic MMPIs have not produced favorable results. In this review, we summarize the results of our in vitro studies evaluating effects of a natural and non-toxic nutrient mixture on inhibition of the cancer biomarkers; MMP-2 and MMP-9 in the treatment and control of metastasis of 42 different cancer cell lines from 13 representative classes of malignancies.
Authors and Affiliations
Aleksandra Niedzwiecki
Keywords
Related Articles
- EP ID EP240040
- DOI 10.13188/2325-2340.1000009
- Views 107
- Downloads 0
Extracellular Domain Mutation of ErbB2 Status in Japanese Lung Cancer Patients
Purpose: The erbB pathway involves a family of tyrosine kinases and has contributed to resistance or sensitivity for chemotherapy in many tumor types. Somatic mutations of the erbB family receptor gene at kinase domain w...
Redefining the HER2 Oncobiomarker: A Relevant Case Report
In multiple studies anti HER2 therapy combined with chemotherapy demonstrated a marked improvement in disease free survival as adjuvant therapy and as treatment for metastatic breast cancer compared to chemotherapy alone...
Mtor-Fanconi Anemia DNA Damage Repair Pathway in Cancer
mTOR is a serine/threonine kinase and plays a critical role in mammalian cell growth, survival, and metabolism. mTOR is present in two cellular complexes: mTORC1 and mTORC2. Dysregulation of the mTOR pathway has been rel...
11β-Hydroxysteroid Dehydrogenase Type II is a Potential Target for Prevention of Colorectal Tumorigenesis
Colorectal cancer (CRC) is a leading cause of cancer death, yet primary prevention remains the best approach to reducing overall morbidity and mortality. There is a clear molecular link between cyclooxygenase-2 (COX-2)-d...
Suppression of Matrix Metalloproteinases -2 and -9 in Various Human Cancer Cell Lines by a Nutrient Mixture
The matrix metalloproteinases (MMPs) are a family of zinc containing endopeptidases that degrade various components of the extra cellular matrix. Among the many types of MMPs that have been identified, MMP-2 (gelatinase...